| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $34.5B | $30.3B | $24.4B | $20.6B | $18.4B |
| Cost of Revenue | $24.4B | $21.4B | $18.2B | $15.9B | $15.5B |
| Gross Profit | $10.1B | $8.8B | — | — | — |
| R&D Expense | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — |
| Operating Income | $0.5B | $0.4B | $0.5B | $-0.1B | $-1.5B |
| Net Income | $0.2B | $0.2B | $1.4B | $-0.1B | $-1.5B |
| EPS (Basic) | $0.11 | $0.09 | $0.76 | $-0.05 | $-1.08 |
| EPS (Diluted) | $0.11 | $0.08 | $0.75 | $-0.05 | $-1.08 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $17.8B | $15.3B | $13.3B | $9.5B | $8.6B |
| Current Assets | $9.7B | $9.0B | $7.9B | $5.8B | $5.6B |
| Cash & Equivalents | $6.3B | $5.9B | $5.2B | $3.5B | $3.5B |
| Total Liabilities | $13.2B | $11.2B | $9.2B | $7.1B | $6.5B |
| Current Liabilities | $9.4B | $7.7B | $6.9B | $5.1B | $4.7B |
| Stockholders' Equity | — | — | $4.1B | $2.4B | $2.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.8B | $1.9B | $2.7B | $0.6B | $-0.4B |
| Investing Cash Flow | $-1.3B | $-0.8B | $-0.9B | $-0.8B | $-0.7B |
| Capital Expenditures | $1.3B | $0.9B | $0.9B | $0.8B | $0.7B |
| Financing Cash Flow | $-0.2B | $-0.1B | $0.2B | $0.2B | $3.6B |